CoChat

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Open access
Bocchetta, Martina, Galluzzi, Samantha, Kehoe, Patrick Gavin, Aguera, Eduardo, Bernabei, Roberto, Bullock, Roger, Ceccaldi, Mathieu, Dartigues, Jean‐François, de Mendonça, Alexandre, Didic, Mira, Eriksdotter, Maria, Félician, Olivier, Frölich, Lutz, Gertz, Hermann‐Josef, Hallikainen, Merja, Hasselbalch, Steen G., Hausner, Lucrezia, Heuser, Isabell, Jessen, Frank, Jones, Roy W., Kurz, Alexander, Lawlor, Brian, Lleo, Alberto, Martinez‐Lage, Pablo, Mecocci, Patrizia, Mehrabian, Shima, Monsch, Andreas, Nobili, Flavio, Nordberg, Agneta, Rikkert, Marcel Olde, Orgogozo, Jean‐Marc, Pasquier, Florence, Peters, Oliver, Salmon, Eric, Sánchez‐Castellano, Carmen, Santana, Isabel, Sarazin, Marie, Traykov, Latchezar, Tsolaki, Magda, Visser, Pieter Jelle, Wallin, Åsa K., Wilcock, Gordon, Wilkinson, David, Wolf, Henrike, Yener, Görsev, Zekry, Dina, Frisoni, Giovanni B. · 2015 · Alzheimer's & Dementia
Cited by 76

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Consortium centers and assessed their perceived usefulness for the etiologic diagnosis of mild cognitive impairment (MCI). We surveyed availability, frequency of use, and confidence in diagnostic usefulness of markers of brain amyloidosis (amyloid positron emission tomography [PET], cerebrospinal fluid [CSF] Aβ42) and neurodegeneration (medial temporal atrophy [MTA] on MR, fluorodeoxyglucose positron emission tomography [FDG‐PET], CSF tau). The most frequently used biomarker is visually rated MTA (75% of the 37 responders reported using it “always/frequently”) followed by CSF markers (22%), FDG‐PET (16%), and amyloid‐PET (3%). Only 45% of responders perceive MTA as contributing to diagnostic confidence, where the contribution was rated as “moderate”. Seventy‐nine percent of responders felt “very/extremely” comfortable delivering a diagnosis of MCI due to AD when both amyloid and neuronal injury biomarkers were abnormal (P < .02 versus any individual biomarker). Responders largely agreed that a combination of amyloidosis and neuronal injury biomarkers was a strongly indicative AD signature.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2014.06.006

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 76

Metadata

Authors
Bocchetta, M., Galluzzi, S., Kehoe, P. G., Aguera, E., Bernabei, R., Bullock, R., Ceccaldi, M., Dartigues, J., de Mendonça, A., Didic, M., Eriksdotter, M., Félician, O., Frölich, L., Gertz, H., Hallikainen, M., Hasselbalch, S. G., Hausner, L., Heuser, I., Jessen, F., Jones, R. W., Kurz, A., Lawlor, B., Lleo, A., Martinez‐Lage, P., Mecocci, P., Mehrabian, S., Monsch, A., Nobili, F., Nordberg, A., Rikkert, M. O., Orgogozo, J., Pasquier, F., Peters, O., Salmon, E., Sánchez‐Castellano, C., Santana, I., Sarazin, M., Traykov, L., Tsolaki, M., Visser, P. J., Wallin, Å. K., Wilcock, G., Wilkinson, D., Wolf, H., Yener, G., Zekry, D., & Frisoni, G. B.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2014-08-21
Volume
11
Issue
2
Pages
195
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2034953421
Cited by
76
References
13
FWCI
5.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. https://app.cochat.ai/papers/10.1016/j.jalz.2014.06.006
The paper
Bocchetta, M., Galluzzi, S., Kehoe, P. G., Aguera, E., Bernabei, R., Bullock, R., Ceccaldi, M., Dartigues, J., de Mendonça, A., Didic, M., Eriksdotter, M., Félician, O., Frölich, L., Gertz, H., Hallikainen, M., Hasselbalch, S. G., Hausner, L., Heuser, I., Jessen, F., . . . Frisoni, G. B. (2015). The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2014.06.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.